Rice Hall James & Associates, LLC Pacira Bio Sciences, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.53 Billion
- Q1 2025
A detailed history of Rice Hall James & Associates, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 257,508 shares of PCRX stock, worth $6.93 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
257,508
Previous 260,185
1.03%
Holding current value
$6.93 Million
Previous $4.9 Million
30.57%
% of portfolio
0.42%
Previous 0.3%
Shares
31 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
49.6MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$215 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$142 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$87.8 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$60.7 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$53.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.23B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...